Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copen-fast: Fiasp vs Novorapid in Pregnancy
NCT03770767Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Nov 2019
- Primary completion
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Birth weight standard deviation score. Started Nov 2019; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03770767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770767.